Some aggressive protocols use up to 0.75 mg daily, particularly for severe injuries or larger individuals
Fibroblast, Tendon-Cell, and Endothelial Research Published in vitro studies using cultured fibroblasts, tendon fibroblasts, tenocytes, and vascular endothelial cells have examined BPC-157-associated effects on migration, viability, extracellular matrix markers, angiogenesis-associated signaling, and proliferation-associated endpoints
Food and Drug Administration has not approved BPC-157 for medical treatment in humans
Key distinction: BPC-157 provides daily, sustained systemic signaling over weeks
Output is for in vitro laboratory research only
Malinda KM, Sidhu GS, Mani H, et al